Metabolon, a Morrisville, NC-based provider of metabolomics solutions that offers variety of research, diagnostic, therapeutic development, and precision medicine applications, raised $25M in funding.
The backers were not disclosed.
The company intends to use the funds to accelerate the commercialization activities and continue advancing its R&D roadmap.
Led by CEO Rohan (Ro) Hastie, Metabolon offers scalable, customizable metabolomics and lipidomics solutions supporting customer needs from discovery through clinical trials and product life-cycle management. In over 20 years, 10,000+ projects, over 3,000 publications, and ISO 9001:2015 and CLIA certifications, the company has developed scientific, technology, and bioinformatics techniques. Its Global Discovery Panel is enabled by a proprietary metabolomics reference library. The
FinSMEs
25/01/2023